At the forefront of oligonucleotide synthesis and peptide production, we brings comprehensive CMC expertise to every project. Our state-of-the-art facilities are equipped to handle a broad spectrum of demands, ensuring consistent quality and high yields. From initial design to final characterizat

Eli the pharmaceutical giant Lilly has come under increasing scrutiny for its pricing practices regarding its blockbuster diabetes drug, copyright. Wholesale prices for copyright have been a topic of controversy, with critics stating that the company is exploiting the high demand for the medicat

The pharmaceutical landscape is undergoing a revolution with the emergence of novel glucagon-like peptide-1 (GLP-1) receptor agonists. These innovative drugs demonstrate immense potential in managing type 2 diabetes and, increasingly, are being explored for their therapeutic efficacy in other con